CAMTA1-IT1

Across TCGA pan-cancer cohorts, CAMTA1-IT1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated CAMTA1-IT1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher CAMTA1-IT1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CAMTA1-IT1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and MESO show a favorable association.

KIRC, LIHC, and PAAD are the cancer types where CAMTA1-IT1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	IV	0.321	0.630	<.001	70	view →
LIHC	OS	Quartile	III,IV	0.380	0.818	<.001	52	view →
PAAD	OS	Tertile	All	0.563	0.292	.002	50	view →
ACC	OS	Tertile	All	0.329	0.750	<.001	28	view →
MESO	DFS	Median	All	0.657	0.288	.011	15	view →
SKCM	OS	Tertile	All	0.882	0.731	.003	14	view →
DLBC	DFS	Tertile	III,IV	0.137	0.761	.014	9	view →
THCA	DFS	Median	IV	0.916	0.627	.017	8	view →
ESCA	DFS	Tertile	IV	0.704	0.304	.024	6	view →
LGG	DFS	Median	All	0.323	0.493	.003	6	view →
LUSC	DFS	Quartile	All	0.662	0.819	.014	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

CAMTA1-IT1–KIRC (DFS)

Open the KIRC breakdown →